Ms. Yan Luying (闫璐颖), aged 43, is an executive Director and a Vice President of our Company. She was appointed as our Vice President on September 1, 2016 when she joined our Group, and was appointed as an executive Director and director of MP CardioFlow on September 29, 2020. Ms. Yan is responsible for regulatory affairs and clinical trial and quality management, and participating in the management and strategic development of our Group.

Ms. Yan has more than 19 years of experience in registration, clinical investigation and management regarding active. non-active, interventional, and implantable devices. Prior to joining our Group in September 2016, Ms. Yan has been working as regulatory affairs senior manager at the MicroPort^® Group from July 2004 to August 2016.

Ms. Yan obtained a bachelor's degree and a master's degree in biomedical engineering from Capital Medical University(首都医科大学) in China in July 2004 and December 2012, respectively.